Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy-Reference-Cited by-同舟云学术

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Published:2016-07-04 Issue:8 Volume:22 Page:851-860
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Jiang Hong,Hegde Samarth^ORCID,Knolhoff Brett L,Zhu Yu,Herndon John M,Meyer Melissa A,Nywening Timothy M,Hawkins William G,Shapiro Irina M,Weaver David T,Pachter Jonathan A,Wang-Gillam Andrea,DeNardo David G

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4123.pdf

Reference56 articles.

1. Royal, R.E. et al. Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J. Immunother. 33, 828–833 (2010).

2. Zhu, Y. et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 74, 5057–5069 (2014).

3. Panni, R.Z., Linehan, D.C. & DeNardo, D.G. Targeting tumor-infiltrating macrophages to combat cancer. Immunotherapy 5, 1075–1087 (2013).

4. Mitchem, J.B. et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression and improves chemotherapeutic responses. Cancer Res. 73, 1128–1141 (2013).

5. Goedegebuure, P. et al. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. Curr. Cancer Drug Targets 11, 734–751 (2011).

Cited by 775 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders;European Journal of Medicinal Chemistry;2024-10

2. Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer;Biomedicine & Pharmacotherapy;2024-10

3. Focal adhesion kinase-mediated interaction between tumor and immune cells in the tumor microenvironment: implications for cancer-associated therapies and tumor progression;Clinical and Translational Oncology;2024-09-13

4. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

5. Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds;Journal of Controlled Release;2024-09